Literature DB >> 17003310

Cholesterol absorption and synthesis in children with type 1 diabetes.

Mikko Järvisalo1, Olli Raitakari, Helena Gylling, Tatu A Miettinen.   

Abstract

OBJECTIVE: The levels of the surrogate markers of cholesterol absorption (cholestanol and plant sterols) and synthesis (cholesterol precursors) in serum have suggested that in adult type 1 diabetes, cholesterol absorption is high and synthesis is low compared with type 2 diabetic or control subjects. Accordingly, these findings were further studied in children with type 1 diabetes. RESEARCH DESIGN AND METHODS: Forty-eight children with diabetes were compared with 79 age- and sex-matched control subjects. The serum ratios of cholesterol absorption and synthesis markers were measured with gas-liquid chromatography. The study population was divided into triads (combining the two lowest triads) by serum cholestanol ratios of the control subjects indicating low to high cholesterol absorption efficiency.
RESULTS: The ratios of the absorption and synthesis markers were similar in case and control subjects, and they were negatively related to each other in control subjects, being less consistent in diabetic patients. Thus, high cholesterol absorption was associated with low synthesis. Plant sterol ratios increased significantly with increasing cholestanol triads in both groups, but the values in the lowest triads were higher in case versus control subjects.
CONCLUSIONS: Homeostasis between cholesterol absorption and synthesis is maintained in control children and somewhat less consistently in those with diabetes. The higher plant sterol ratios in diabetic versus control subjects in the lowest cholestanol triads suggest that cholesterol absorption is higher in children with diabetes versus control subjects but only within the range of low cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003310     DOI: 10.2337/dc05-2235

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Amy S Shah; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; Franziska K Bishop; David M Maahs; Lawrence M Dolan; Clary B Clish; Sudha B Biddinger
Journal:  J Clin Lipidol       Date:  2019-09-25       Impact factor: 4.766

2.  Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.

Authors:  Helena Gylling; Maarit Hallikainen; Jussi Pihlajamäki; Piia Simonen; Johanna Kuusisto; Markku Laakso; Tatu A Miettinen
Journal:  J Lipid Res       Date:  2010-05-01       Impact factor: 5.922

3.  Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.

Authors:  Jan Freark de Boer; Wijtske Annema; Marijke Schreurs; Jelske N van der Veen; Markus van der Giet; Niels Nijstad; Folkert Kuipers; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2011-12-18       Impact factor: 5.922

4.  Do plant sterol concentrations correlate with coronary artery disease in type 1 diabetes? A report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Christina Marie Shay; Rhobert Wyn Evans; Trevor John Orchard
Journal:  J Diabetes       Date:  2009-06       Impact factor: 4.006

5.  Plasma plant sterol levels do not reflect cholesterol absorption in children with Smith-Lemli-Opitz syndrome.

Authors:  Louise S Merkens; Julia M Jordan; Jennifer A Penfield; Dieter Lütjohann; William E Connor; Robert D Steiner
Journal:  J Pediatr       Date:  2008-12-21       Impact factor: 4.406

6.  Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia.

Authors:  Kazuo Azuma; Tomone Nagae; Takeshi Nagai; Hironori Izawa; Minoru Morimoto; Yusuke Murahata; Tomohiro Osaki; Takeshi Tsuka; Tomohiro Imagawa; Norihiko Ito; Yoshiharu Okamoto; Hiroyuki Saimoto; Shinsuke Ifuku
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

7.  Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Authors:  Karen Alejandra Méndez-Lara; David Santos; Núria Farré; Sheila Ruiz-Nogales; Sergi Leánez; José Luis Sánchez-Quesada; Edgar Zapico; Enrique Lerma; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Jesús María Martín-Campos; Josep Julve; Olga Pol
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.